Anthracycline cardiotoxicity equivalence ratio

Chairs

Annelies M.C. Mavinkurve-Groothuis, Princess Máxima Center for pediatric oncology, Utrecht, the Netherlands
Matthew J. Ehrhardt, St. Jude Children’s Research Hospital, Memphis, United States

Coordinator

Theodorus W. Kouwenberg, Princess Máxima Center for pediatric oncology, Utrecht, the Netherlands

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Elvira C. van Dalen, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom

WG members

Bianca F. Goemans, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Eric J. Chow, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA and Fred Hutchinson Cancer Research Center, Seattle, United States
Helen Kosmidis, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece
Athanasios Tragiannidis, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece
Britta J. Vormoor-Burger, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Saro Armenian, City of Hope National Medical Center, Duarte, United States
Chikako Kiyotani, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
Elisabeth A.M. Feijen, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Paul C. Nathan, The Hospital for Sick Children, The University of Toronto, Toronto, Canada
Livia Kapusta, Amalia Children’s Hospital, Radboud university medical center, Nijmegen, The Netherlands and Tel Aviv Sourasky Medical Centre, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Heynric B. Grotenhuis, University Medical Center Utrecht, Wilhelmina Children’s Hospital, Utrecht, the Netherlands
Frederike K. Engels, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Arco J. Teske, University Medical Center Utrecht, Utrecht, the Netherlands
Martijn G. Slieker, University Medical Center Utrecht, Wilhelmina Children’s Hospital, Utrecht, the Netherlands
Shuichi Ozono, Department of Pediatrics, Kurume University, Kurume, Japan
Anju Nohria, Brigham and Women’s Hospital, Boston, United States
Tomáš Sláma, Swiss Childhood Cancer Survivor Study, University of Bern Institute of Social and Preventive Medicine, Bern, Switzerland